Renal failure vaccine - Protherics

Drug Profile

Renal failure vaccine - Protherics

Alternative Names: Kidney failure vaccine - Protherics; Nephropathy immunotherapeutic - Protherics; Renal vaccine - Protherics

Latest Information Update: 23 Nov 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Protherics
  • Developer BTG
  • Class Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Renal failure

Most Recent Events

  • 04 Dec 2008 Protherics has been acquired and merged into BTG
  • 02 Oct 2001 Preclinical development for Renal failure in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top